Medpace Expands Infectious Diseases & Vaccines Medical Leadership Team
Medpace is pleased to announce that Dr. Arlene Dent has joined Medpace’s infectious diseases and vaccines medical leadership team.
Medpace Expands Vaccines and Women’s Health Leadership Team
Medpace is pleased to announce the addition of a new clinical operations expert, Beth Tulip, to its leadership team. In this interview, we learn more…
A New Paradigm in Infectious Diseases Treatment & Prophylaxis Shaped by the Current Pandemic
The COVID-19 pandemic will end, or as any pandemic in the past, will lose its momentum. Yet, the precedents and the new paradigms formed in…
Webinar: Revisiting and Rebuilding Clinical Development of Drugs for Antimicrobial Resistance – Lessons Learned During the COVID-19 Pandemic
Join AMR experts from Medpace, IHMA, and GARDP as they discuss how we can use the momentum from the pandemic to rethink, rebuild and revitalize…
Infectious Diseases in the Immunocompromised Host
An in-depth look at infectious diseases including hematologic malignancies in immunocompromised patients and the unique challenges for clinical development.
Medpace Bolsters Medical Leadership in Infectious Diseases and Asia-Pac Region
Medpace (MEDP) a scientifically-driven, global, full-service clinical contract research organization (CRO) known for its strong scientific expertise, announced the addition...
Decreasing Timelines in Infectious Diseases Drug Development
Nothing derails a clinical study timeline more than poor planning and not anticipating and preparing for potential roadblocks. While you may not be able to…
The Potential Power of the Human Microbiome for Drug Development
The dynamic nature of the microbiome is driving momentum and enthusiasm for clinical research. Recent advances in analyzing the microbiome and how it impacts immunity…
New Whitepaper: The Microbiome in Clinical Trials – Opportunities and Challenges
Medpace and Diversigen discuss the opportunities and challenges of the microbiome in clinical trials in a recently published whitepaper. You can access the whitepaper in…
Q&A with Dr. Brian Murphy, VP of Medical Affairs for Infectious Diseases
In this post, Dr. Brian Murphy, Vice President of Medical Affairs for Infectious Diseases, discusses the following topic: “Source Control Review in Clinical Trials of…